sellWeak
Douglas A Treco sold $7,849 of INZY
CEO & Chairman at Inozyme Pharma, Inc.. 8,819 shares at an average of $0.89, traded Apr 2, 2025, filed Apr 3, 2025.
Warning score
15Value
$7,849
8,819 shares
Holdings after
41,046
-18% from before
From 52-week low
-
no price yet
From 52-week high
-
no price yet
Score components
- +25RoleCEO
- 0Trade size$8k at market
- +5Share of holdings soldSold 18% of holdings
- 0ClusterNo other insider selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Rows in this filing
Every transaction in Form 4 0000950170-25-050443, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Apr 1, 2025 | MOption exercise Common Stock | +25,000 | - | - | 49,865 | Apr 3, 2025 |
| Apr 2, 2025 | SOpen-market sale Common Stock | -8,819 | $0.89 | $7,849 | 41,046 | Apr 3, 2025 |
| Apr 1, 2025 | MOption exercise Restricted Stock Unitsderivative | -25,000 | $0.00 | $0 | 50,000 | Apr 3, 2025 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.